AlphaQ Advisors’s CVS Health CVS Stock Holding History

AlphaQ Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$20.7K	–	174
2023 Q2	$20.7K	Buy	+300	New	+$21.3K	0.02%	178

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AlphaQ Advisors's CVS Position: Q2 2024 in Review

AlphaQ Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 5,639 shares — an estimated $450K sold.

AlphaQ Advisors first reported a position in CVS in Q4 2022 and held it in 6 quarters. The position peaked at $489K in Q4 2022. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

AlphaQ Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
AlphaQ Advisors sold 5,639 CVS Health shares in Q2 2024, an estimated $450K.
AlphaQ Advisors first reported a position in CVS Health in Q4 2022 and held it in 6 quarters.
AlphaQ Advisors's CVS Health position peaked at $489K in Q4 2022.
1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on AlphaQ Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.